Enlivex Therapeutics Ltd
General ticker "ENLV" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $24.7M
Enlivex Therapeutics Ltd does not follow the US Stock Market performance with the rate: -32.7%.
Estimated limits based on current volatility of 2.8%: low 1.16$, high 1.23$
Factors to consider:
- Current price 34.6% below estimated low
- Earnings for 18 months up through Q2 (+1 year) are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [2.34$, 5.27$]
- 2023-12-31 to 2024-12-30 estimated range: [1.90$, 4.35$]
Financial Metrics affecting the ENLV estimates:
- Negative: Non-GAAP EPS, $ of -1.46 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -23.47 <= 2.35
- Positive: Interest expense per share, $ of 0.29 <= 0.74
- Positive: Inventory ratio change, % of 0 <= 0
Short-term ENLV quotes
Long-term ENLV plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $19.29MM | $25.80MM | $29.39MM |
| Operating Income | $-19.29MM | $-25.80MM | $-29.39MM |
| Non-Operating Income | $4.82MM | $-5.26MM | $0.33MM |
| Interest Expense | $0.33MM | $5.26MM | $0.01MM |
| R&D Expense | $12.88MM | $18.69MM | $19.23MM |
| Income(Loss) | $-14.47MM | $-31.06MM | $-29.07MM |
| Taxes | $-4.82MM | $11.35MM | $0.00MM |
| Profit(Loss) | $-9.65MM | $-42.41MM | $-29.07MM |
| Stockholders Equity | $85.04MM | $56.84MM | $30.08MM |
| Inventory | $12.20MM | $1.18MM | $0.00MM |
| Assets | $95.15MM | $67.64MM | $36.83MM |
| Operating Cash Flow | $-17.54MM | $-23.95MM | $-23.52MM |
| Capital expenditure | $1.62MM | $8.12MM | $0.24MM |
| Investing Cash Flow | $-38.41MM | $62.52MM | $-25.97MM |
| Financing Cash Flow | $60.98MM | $0.15MM | $0.36MM |
| Earnings Per Share* | $-0.54 | $-2.31 | $-1.56 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.